Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Primary Immunodeficiency Diseases 1Neoplasms 1Infections 1Epstein-Barr Virus Infections 1

Interventions

AP 1903 reagent 3threonic acid 1fludarabine phosphate 1fludarabine 1Thiotepa 1Tacrolimus 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Magnesium Sulfate 1Cyclophosphamide 1Busulfan 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Primary Immunodeficiency Diseases × Magnesium Sulfate × Clear all
NCT02496676 2022-03-02

Magnesium Supplementation in People With XMEN Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
8 enrolled 7 charts

Primary Immunodeficiency Diseases, Infections, Neoplasms, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡